Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
The pathogenesis of systemic lupus erythematosus (SLE) is multifactorial and multigenetic. The apoptosis genes, fas and fas ligand (fasL), are candidate contributory genes in human SLE, as mutations of these genes result in autoimmunity in several murine models of this disease. In humans, fas mutati...
Zapisane w:
| Wydane w: | J Clin Invest |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Clinical Investigation
1996
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507531/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8787672/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118892 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
